Active Shortage Injection Oncology
Azacitidine Injection · 2,089 days since initial FDA posting
Brand: AZACITIDINE
FDA lists Azacitidine Injection as Active Shortage (Teva Pharmaceuticals USA, Inc.).
Availability on file: Unavailable
Azacitidine Injection: Active Shortage
Unavailable Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Azacitidine Injection
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Dosage Form
- Injection
- Presentation
- Azacitidine, Injection, 100 mg (NDC 68001-313-56)
- Package NDC
- 68001-313-56
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Dec 22, 2020
- Last Updated
- Mar 16, 2026
- Therapeutic Category
- Oncology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Unavailable
Nearby, Other Azacitidine Shortage Records
Azacitidine Injection
Meitheal Pharmaceuticals, Inc.
Injection
Azacitidine Injection
Eugia US LLC
Injection
Azacitidine Injection
Fresenius Kabi USA, LLC
Injection
Azacitidine Injection
Bristol Myers Squibb Co.
Injection
Azacitidine Injection
Accord Healthcare Inc.
Injection
Azacitidine Injection
Dr. Reddy's Laboratories, Inc.
Injection
FDA reason on file: Unavailable. General shortage guidance lives on the tracker hub.